Brief: Vincerx Pharma Regains Compliance With Nasdaq Listing Rule 5550(A)(2)
18/02/2025 22:27
Feb 18 (Reuters) - Vincerx Pharma Inc VINC.O :
* VINCERX PHARMA INC - REGAINS COMPLIANCE WITH NASDAQ
LISTING RULE
5550(A)(2)
Source text: ID:n0001193125-25-028591
Further company coverage: VINC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vincerx Pharma
See all newsBrief: Vincerx Pharma Announces Intent To Delist From Nasdaq And Deregister With The SEC
Brief: Vincerx Pharma Announces Termination Of Letter Of Intent And Board Authorization To Pursue Wind-Down Activities
Vincerx Pharma Inc reports results for the quarter ended December 31 - Earnings Summary
Vincerx Pharma Inc expected to post a loss of $3.40 a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Aditxt, Natgas companies, DocuSign